NetworkNewsBreaks - Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Closes $48M Follow-On

(NetworkNewsWire via Comtex)

Mirum Pharmaceuticals (NASDAQ: MIRM), a biopharmaceutical company concentrating on the development and commercialization of novel therapies for debilitating liver diseases, recently closed an underwritten public offering of 2,400,000 shares of its common stock. Sold at a price of $20.00 each, the offering resulted in gross proceeds of $48 million. Additionally, the company granted the underwriters a 30-day option to purchase up to 360,000 shares at the public offering price of $20.00 per share. ROTH Capital Partners served as co-manager for the offering.

To view the full press release, visit http://nnw.fm/5xnIc

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis ("PFIC") and Alagille syndrome ("ALGS"). For more information, visit the company's website at https://MirumPharma.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork.